- Ticker
- AEMD
- Price
- 0.61
- Stock movement down
- -0.05 (-7.76%)
- Company name
- Aethlon Medical Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Medical Devices
- Markedsverdi
- 13.97M
- Ent verdi
- -2.46M
- Pris/omsetning
- 462.07
- Pris/bok
- 0.70
- Utbytte avkastning
- -
- Utbytte vekst
- -
- Vekst år
- -
- FCF-utbetaling
- -
- Etterfølgende P/E
- -
- Fremtidig P/E
- -
- PEG
- -
- EPS-vekst
- -
- 1 års avkastning
- -59.41%
- 3 års avkastning
- -38.68%
- 5 års avkastning
- -50.57%
- 10 års avkastning
- -36.49%
Sist oppdatert: 2023-02-03
UTBYTTE
AEMD betaler ikke utbytte
VERDSETTELSE
Verdsettelsesforhold
Loading...
Verdsettelsesforhold-data
| Etterfølgende P/E | - |
| Pris til OCF | - |
| Pris til FCF | - |
| Pris til EBITDA | - |
| EV i forhold til EBITDA | - |
Verdsettelse (Salg/Bokført verdi)
Loading...
Verdsettelse (Salg/Bokført verdi) data
| Pris til omsetning | 462.07 |
| Pris til bok | 0.70 |
| EV i forhold til salg | -81.22 |
ØKONOMI
Per aksje
Loading...
Per aksje-data
| Gjeldende aksje antall | 22.95M |
| EPS (TTM) | -0.63 |
| FCF per aksje (TTM) | -0.60 |
Resultatregnskap
Loading...
Resultatregnskap-data
| Inntekter (TTM) | 30.23K |
| Bruttofortjeneste (TTM) | 17.12K |
| Driftsinntekter (TTM) | -12.89M |
| Netto inntekt (TTM) | -13.03M |
| EPS (TTM) | -0.63 |
| EPS (1 år fremover) | -0.71 |
Marginer
Loading...
Marginer-data
| Bruttomargin (TTM) | 56.62% |
| Driftsmargin (TTM) | -42619.11% |
| Fortjenestemargin (TTM) | -43085.77% |
Balanse
Loading...
Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
Balanse-data
| Kontanter | 19.60M |
| Netto fordringer | 114.85K |
| Samlede omløpsmidler | 20.50M |
| Goodwill | 0.00 |
| Immaterielle eiendeler | 1.93K |
| Eiendom, anlegg og utstyr | 0.00 |
| Sum eiendeler | 23.05M |
| Leverandørgjeld | 361.00K |
| Kortsiktig/nåværende langsiktig gjeld | 1.32M |
| Sum kortsiktig gjeld | 2.10M |
| Sum gjeld | 3.18M |
| Aksjonærenes egenkapital | 19.87M |
| Netto varige driftsmidler | 19.87M |
Kontantstrøm
Loading...
Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
Kontantstrøm-data
| Kontantstrøm fra drift (TTM) | -11.42M |
| Kapitalutgifter (TTM) | 1.05M |
| Fri kontantstrøm (TTM) | -12.48M |
| Utbetalt utbytte (TTM) | 0.00 |
Finansielle inntekter
Loading...
Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
Finansielle inntekter-data
| Egenkapitalavkastning | -65.56% |
| Avkastning på eiendeler | -56.52% |
| Avkastning på investert kapital | -64.76% |
| Kontantavkastning på investert kapital | -62.02% |
AKSJEINFORMASJON
Aksjediagram
Loading...
Aksjekurs-data
| Åpning | 0.66 |
| Daglig høy | 0.69 |
| Daglig lav | 0.59 |
| Daglig volum | 630K |
| Tidenes høyeste | 6750.00 |
| 1 år analytikerestimat | 8.50 |
| Beta | 0.89 |
| EPS (TTM) | -0.63 |
| Utbytte per aksje | - |
| Ex-div dato | - |
| Neste dato for resultatpresentasjon | 13 Feb 2023 |
Nedsidepotensial
Loading...
Nedsidepotensial-data
| AEMD | S&P500 | |
| Nåværende prisfall fra toppnotering | -99.99% | -13.68% |
| Høyeste prisfall | -100.00% | -56.47% |
| Dato for høyeste fall | 28 Dec 2022 | 9 Mar 2009 |
| Gj.snittlig fall fra topp | -94.94% | -11.49% |
| Gj.snittlig tid til ny topp | 195 days | 13 days |
| Maks tid til ny topp | 5238 days | 1805 days |
SELSKAPSOPPLYSNINGER
Markedsverdi
13.97M
Markedsverdi kategori
Small-cap
Beskrivelse
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.
Ansatte
14
Nettsted
Investorrelasjoner
-
SEC-innsendelser
Adm. direktør
Timothy C. Rodell
Land
USA
By
San Diego
Aksjetype
Common stock
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRESENTASJONER
ArrangementerPresentasjoner
Loading...
FORSTÅ VIRKSOMHETEN
Loading...
NYHETER OM SELSKAPET
Alle nyheterPressemeldinger
Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious disease, announced today that it will be presenting virtually at the upcom...
31. januar 2023
Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious diseases, today announced that it has entered into an agreement with NAMSA...
30. januar 2023
By M. Marin NASDAQ:AEMD READ THE FULL AEMD RESEARCH REPORT Studying the Hemopurifier in a range of cancers Aethlon Medical’s (NASDAQ:AEMD) provided a business update. AEMD has been working to launch a...
16. november 2022
Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life threatening infectious diseases, today reported financial resul...
14. november 2022
Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical therapeutics to treat cancer and life-threatening infectious disease, today announced that it will issue financial results for its se...
2. november 2022
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.comNEW YORK, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor c...
12. september 2022
Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life-threatening infectious diseases, today announced that it will b...
6. september 2022
By M. Marin NASDAQ:AEMD READ THE FULL AEMD RESEARCH REPORT Expanding the Potential Indications for Hemopurifier Treatment Aethlon Medical’s (NASDAQ:AEMD) clinical trials are moving forward and expandi...
17. august 2022
With the business potentially at an important milestone, we thought we'd take a closer look at Aethlon Medical, Inc.'s...
15. august 2022
In this article, we will look at 10 healthcare and biotech stocks to buy amid the monkeypox threat. If you want to explore similar healthcare and biotech stocks, you can also take a look at 5 Healthca...
10. august 2022
Neste side